M
Masahiko Yano
Researcher at Niigata University
Publications - 198
Citations - 4432
Masahiko Yano is an academic researcher from Niigata University. The author has contributed to research in topics: Esophagectomy & Cancer. The author has an hindex of 30, co-authored 198 publications receiving 3547 citations. Previous affiliations of Masahiko Yano include The Nippon Dental University.
Papers
More filters
Journal ArticleDOI
Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice.
Toshimasa Tsujinaka,J. Fujita,C Ebisui,Masahiko Yano,Eiki Kominami,K Suzuki,Keiji Tanaka,A Katsume,Y Ohsugi,H. Shiozaki,M. Monden +10 more
TL;DR: In this paper, the anti-mouse IL-6 receptor (mIL-6R) antibody was used to prevent muscle atrophy in 16-week-old transgenic mice.
Journal ArticleDOI
A novel image-guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation
Kunihito Gotoh,Terumasa Yamada,Osamu Ishikawa,Hidenori Takahashi,Hidetoshi Eguchi,Masahiko Yano,Hiroaki Ohigashi,Yasuhiko Tomita,Yasuhide Miyamoto,Shingi Imaoka +9 more
TL;DR: A novel indocyanine green (ICG) fluorescence imaging technique is presented to visualize hepatocellular carcinoma (HCC) and shows clear delineation between tumor and normal tissue.
Journal ArticleDOI
Risk of Recurrence in a Long-term Follow-up After Surgery in 417 Patients With Hepatitis B- or Hepatitis C-Related Hepatocellular Carcinoma
Yo Sasaki,Terumasa Yamada,Hideo Tanaka,Hiroaki Ohigashi,Hidetoshi Eguchi,Masahiko Yano,Osamu Ishikawa,Shingi Imaoka +7 more
TL;DR: Hepatitis viral type is an independent factor for recurrence of HCC in a long-term clinical follow-up and suggests that a different strategy may need to be used to control postoperative recurrence by the viral types in HCC patients.
Journal ArticleDOI
Preoperative gemcitabine-based chemoradiation therapy for resectable and borderline resectable pancreatic cancer.
Hidenori Takahashi,Hiroaki Ohigashi,Kunihito Gotoh,Shigeru Marubashi,Terumasa Yamada,Masayuki Murata,Tatsuya Ioka,Hiroyuki Uehara,Masahiko Yano,Osamu Ishikawa +9 more
TL;DR: In the resected cases, the locoregional control was comparable between patients with PC-R and PC-BR after preoperative CRT, and the survival rate was lower than the rate for those with PCs, due to a higher incidence of peritoneal and distant recurrence in the patients withPC-BR.
Journal ArticleDOI
Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer.
Hiroaki Ohigashi,Osamu Ishikawa,Hidetoshi Eguchi,Hidenori Takahashi,Kunihito Gotoh,Terumasa Yamada,Masahiko Yano,Akihiko Nakaizumi,Hiroyuki Uehara,Yoshihiko Tomita,Kinji Nishiyama +10 more
TL;DR: Results of this trial suggest that a combination of preoperative full-dose gemcitabine, concurrent 3D-conformal radiation, surgery, and postoperative LPC is feasible for the treatment of T3-pancreatic cancer.